H K Stummvoll
Overview
Explore the profile of H K Stummvoll including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sterrett J, Strom J, Stummvoll H, Bahner U, Disney A, Soroka S, et al.
Clin Nephrol
. 2007 Aug;
68(1):10-7.
PMID: 17703830
Aims: This 1-year double-blind, placebo-controlled, multicenter study evaluated the long-term safety and efficacy of cinacalcet for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis. Method: Patients were randomly assigned...
2.
Franz M, Regele H, Schmaldienst S, Stummvoll H, Horl W, Pohanka E
Transplantation
. 1998 Nov;
66(9):1258-62.
PMID: 9825827
Background: Posttransplant hemolytic uremic syndrome (pHUS) is a rare but severe disorder that confers a poor prognosis on an allograft due to thrombotic microangiopathy. Immunosuppression with cyclosporine (CsA) is implicated...
3.
Weber C, Stummvoll H, Passon S, Falkenhagen D
Int J Artif Organs
. 1998 Aug;
21(6):335-40.
PMID: 9714027
With the on-line preparation of substitution fluid, an easy-to-operate and cost-effective alternative to conventional hemodiafiltration (HDF) has been realized. The continuous filtration of dialysis fluid, furthermore, allows high volumes of...
4.
Haas M, Yilmaz N, Schmidt A, Neyer U, Arneitz K, Stummvoll H, et al.
Kidney Blood Press Res
. 1998 Jul;
21(1):66-9.
PMID: 9661139
Angiotensin-converting enzyme (ACE) inhibitors are known to reduce blood pressure and proteinuria in a variety of different glomerular diseases. Nonetheless, a marked interindividual difference in the efficacy of these agents...
5.
Koenig P, Vogel W, Umlauft F, Weyrer K, Prommegger R, Lhotta K, et al.
Kidney Int
. 1994 May;
45(5):1507-9.
PMID: 8072265
No abstract available.
6.
Stummvoll H
Klin Anasthesiol Intensivther
. 1993 Jan;
45:27-35.
PMID: 8271768
No abstract available.
7.
Mayer G, Thum J, Cada E, Stummvoll H, Graf H
Nephron
. 1989 Jan;
51 Suppl 1:34-8.
PMID: 2915781
In earlier studies we have shown that partial correction of anemia by recombinant human erythropoietin (r-HuEPO) already after 12 weeks results in a significant increase of exercise capacity in patients...
8.
Stummvoll H, Schindl R, Aigner K, Wurtz J, Breitenfellner P, Graf H
Wien Med Wochenschr Suppl
. 1989 Jan;
104:suppl 50-2.
PMID: 2588636
No abstract available.
9.
Mayer G, Thum J, Cada E, Stummvoll H, Graf H
Kidney Int
. 1988 Oct;
34(4):525-8.
PMID: 3199672
To investigate the effect of partial correction of anemia in patients maintained by chronic intermittent hemodialysis on aerobic and anaerobic working capacity, eight patients underwent a bicycle spiro-ergometry before and...
10.
Watschinger B, Graf H, Kovarik J, Jarisch R, Leitner E, Stummvoll H, et al.
Wien Med Wochenschr
. 1988 Mar;
138(5):110-2.
PMID: 3388873
The presence of antibodies against ethylene oxide, which is used for sterilization of dialyzers, was evaluated in 52 hemodialysis patients (30 male, 22 female). The aim of the prospective study...